Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E. David in June 2002 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
Frequently Asked Questions
What is Market Cap of Achaogen, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Achaogen, Inc. market cap is $935,200.00.
What is the 52-week high for Achaogen, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Achaogen, Inc. 52 week high is $9.66 as of November 09, 2025.
What is the 52-week low for Achaogen, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Achaogen, Inc. 52 week low is $0.015 as of November 09, 2025.
What is Achaogen, Inc. stock price today?
Achaogen, Inc. stock price today is $0.018.
What was Achaogen, Inc. stock price yesterday?
Achaogen, Inc. stock price yesterday was $0.019.
What is the PE ratio of Achaogen, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Achaogen, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Achaogen, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Achaogen, Inc. P/B ratio is -0.1488.
What is Achaogen, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Achaogen, Inc.'s EBITDA is N/A.
What is the 50-day moving average of Achaogen, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Achaogen, Inc. 50-day moving average is $0.0861.
